Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
1 clinical trials · Condition
◉ Watch Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL) (NCT05155839) | Shanghai Miracogen Inc. | 2019-06-25 |
Track Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL) automatically
Every clearance here is in the API, with alerts when new ones post.